Is iSpecimen Inc. (ISPC) a Buy, Sell, or Hold?
NASDAQ : ISPC
iSpecimen Inc.
$2.225 USD
-$0.01 (-0.22%)
- Volume
- 16.29K
- Average Volume
- 674.68K
- Market Capitalization
- $308.97K
- P/E Ratio
- -0.01
- Dividend Yield
- 0.00%
- Price Target
- Year High
- $127.20
- Year Low
- $2.16
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $0.62
Industry, Sector & symbol
| Stock Exchange | NASDAQ |
| CEO | Katharyn Field |
| Industry | Medical - Diagnostics & Research |
| Sector | Healthcare |
| Current Symbol | ISPC |
| CUSIP | 45032V306 |
| CIK | 0001558569 |
| Web | https://ispecimen.com |
| Phone | 781 301 6700 |
| Currency | USD |
| Employees | 7 |
| Country | US |
Liquidity
| Debt-to-Equity Ratio | 0.31 |
| Payout Ratio | 0.00 |
| Current Ratio | 0.62 |
| Quick Ratio | 0.62 |
| Cash Ratio | 0.50 |
Sales & Book Value
| Annual Sales | $1.93M |
| Price / Sales | 0.30 |
| Cash Flow | -2199.55 |
| Price / Cash Flow | -0.04 |
| Price / Book | 0.01 |
Price Target and Rating
| Average Stock Price Forecast | |
| High Stock Price Forecast | |
| Low Stock Price Forecast | |
| Forecast Upside/Downside | % |
| Consensus Rating | Sell |
| Rating Score(0-5) | 2 |
| Research Coverage | 2 Analysts |
Profitability
| EPS (Most Recent Fiscal Year) | -$91.2 |
| Trailing P/E Ratio | -0.01 |
| PEG Ratio | 0.00 |
| P/E Growth | 0.00 |
| Net Income | -$10.49M |
| Net Margin | -1080.72% |
| Pretax Margin | -1080.72% |
| Return on Equity | -584.67% |
| Return on Assets | -168.00% |
Financials Score
| AltmanZ Score | -23.66 |
| Piotroski Score | 4.00 |
| Working Capital | -2.12M |
| Total Assets | 6.61M |
| Ebit | -11.1M |
| Market Cap | 309.66K |
| Total Liabilities | 5.8M |
Poll Results
About iSpecimen Inc. (NASDAQ:ISPC) Stock
iSpecimen Inc. operates a sophisticated technological platform that effectively bridges the gap between life science researchers and crucial human biological materials. Its proprietary cloud-based system empowers scientists to efficiently locate and access a vast array of biospecimens—such as biofluids, tissues, and living cells—as well as connect with potential study subjects, all sourced from a global network of healthcare providers, including hospitals, laboratories, biobanks, and blood centers. The company develops and manages iSpecimen Marketplace, an innovative online hub that strategically links medical researchers requiring access to subjects, samples, and pertinent data with organizations that hold these invaluable resources. iSpecimen's clientele primarily includes biopharmaceuti ... cal firms, in vitro diagnostics companies, and governmental and academic research institutions. The company, established in 2009, is headquartered in Lexington, Massachusetts.
2026-05-12 14:16:14
NEW YORK, May 12, 2026 (GLOBE NEWSWIRE) -- E. F. Hutton and Co. ("E. F.
2026-05-12 14:16:00
NEW YORK, May 12, 2026 (GLOBE NEWSWIRE) -- E.F. Hutton & Co. (“E.F. Hutton”), an investment banking and financial advisory firm headquartered in New York City, today announced that it acted as the exclusive placement agent in connection with a $2.5 million private placement for iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects scientists requiring biospecimens for medical research with a network of healthcare specimen providers.
iSpecimen Inc. Announces Pricing of Approximately $2.5 Million Private Placement
2026-05-08 21:04:00
May 8, 2026 WOBURN, Mass., May 08, 2026 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects scientists requiring biospecimens for medical research with a network of healthcare specimen providers, today announced that it has priced a private placement with accredited investors for aggregate gross proceeds of approximately $2.5 million, before deducting fees to the placement agent and other offering expenses payable by the Company.
iSpecimen Announces 1-for-40 Reverse Stock Split
2026-04-24 09:00:00
Woburn, Massachusetts--(Newsfile Corp. - April 24, 2026) - iSpecimen Inc. (NASDAQ: ISPC) ("iSpecimen" or the "Company"), an online global marketplace that connects scientists requiring biospecimens for medical research with a network of healthcare specimen providers, announced today that it will effect a reverse stock split of its issued and outstanding shares of common stock, par value $0.0001 per share, as well as any shares of common stock held by the Company in treasury, at a ratio of 1-for-40. The reverse stock split will become effective at 4:30 p.m.
Why iSpecimen Shares Are Surging On Friday?
2026-04-17 12:21:41
iSpecimen Inc (NASDAQ: ISPC) stock is trading higher Friday after announcing a shipping overhaul that slashes transit times by up to 85%.
Frequently Asked Questions
-
What is the current iSpecimen Inc. (ISPC) stock price?
-
iSpecimen Inc.(NASDAQ:ISPC) stock price is $2.225 in the last trading session. During the trading session, ISPC stock reached the peak price of $127.2 while $2.16 was the lowest point it dropped to. The percentage change in ISPC stock occurred in the recent session was --0.22% while the dollar amount for the price change in ISPC stock was -$0.01.
-
ISPC's industry and sector of operation?
-
The NASDAQ listed ISPC is part of Medical - Diagnostics & Research industry that operates in the broader Healthcare sector.
-
Who are the executives of ISPC?
-
Katharyn Field | Chief Executive Officer, President, Secretary & Treasurer
Yuying Liang | Chief Financial Officer
|
|
| -
How many employees does ISPC have?
-
Number of ISPC employees currently stands at 7. ISPC operates from 450 Bedford Street, Woburn, MA 02420, US.
-
Link for ISPC official website?
-
Official Website of ISPC is: https://ispecimen.com
-
How do I contact ISPC?
-
ISPC could be contacted at phone #781 301 6700 and can also be accessed through its website. ISPC operates from 450 Bedford Street, Woburn, MA 02420, US.
-
How many shares of ISPC are traded daily?
-
The average number of ISPC shares traded daily for last 3 months was 674.68K.
-
What is the market cap of ISPC currently?
-
The market value of ISPC currently stands at $308.97K with its latest stock price at $2.225